Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Serprozyme ApS
APS
Active
Advertising protection
CVR 44083205
Ølstvadbrovej 31, 8940
Randers SV
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2023 · 3 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Serprozyme ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2023
0M
0%
2024
Income statement
DKK thousands
Item
2023
2024
Gross profit
-2
31
Staff expenses
-0
-0
EBITDA
-2
31
Depreciation & amort.
-0
-0
EBIT
-2
31
Net financials
0
0
Profit before tax
-2
31
Tax
-0
7
Net profit
-2
25
Balance sheet
DKK thousands
Item
2023
2024
Total assets
38
69
Equity
38
62
Long-term debt
0
0
Short-term debt
0
7
Total debt
0
7
Financial ratios
5-year trend
EBITDA margin (of gross profit)
100.0%
This company
2023
2024
Equity ratio
90.1%
This company
38.2%
Market median
+136% vs market
2023
2024
Return on equity
39.3%
This company
18.4%
Market median
+114% vs market
2023
2024
Net profit margin (of gross profit)
79.0%
This company
2023
2024
Asset turnover (of gross profit)
0.45×
This company
2023
2024
Debt / equity
0.11×
This company
0.62×
Market median
+82% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-05-26 – 2023-12-31
View
PDF
More on Serprozyme ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
